Skip to content

N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[5-(1-methylpyrrol-3-yl)benzimidazol-1-yl]phenyl]acetamide

C27H27N5O2 — CID 134154626

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACN-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[5-(1-methylpyrrol-3-yl)benzimidazol-1-yl]phenyl]acetamide
SMILESCn1ccc(-c2ccc3c(c2)ncn3-c2ccc(CC(=O)Nc3cc(C(C)(C)C)on3)cc2)c1
InChIInChI=1S/C27H27N5O2/c1-27(2,3)24-15-25(30-34-24)29-26(33)13-18-5-8-21(9-6-18)32-17-28-22-14-19(7-10-23(22)32)20-11-12-31(4)16-20/h5-12,14-17H,13H2,1-4H3,(H,29,30,33)
InChIKeyREQJIWOWTBYYLI-UHFFFAOYSA-N
MW453.55 g/mol
LogP5.50
Rot. Bonds5

About N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[5-(1-methylpyrrol-3-yl)benzimidazol-1-yl]phenyl]acetamide

N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[5-(1-methylpyrrol-3-yl)benzimidazol-1-yl]phenyl]acetamide (PubChem CID 134154626) has the molecular formula C27H27N5O2 and a molecular weight of 453.55 g/mol. Its IUPAC name is N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[5-(1-methylpyrrol-3-yl)benzimidazol-1-yl]phenyl]acetamide.

Molecular Properties

Compound NameN-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[5-(1-methylpyrrol-3-yl)benzimidazol-1-yl]phenyl]acetamide
PubChem CID134154626
Molecular FormulaC27H27N5O2
Molecular Weight453.55 g/mol
Exact Mass453.22
IUPAC NameN-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[5-(1-methylpyrrol-3-yl)benzimidazol-1-yl]phenyl]acetamide
SMILESCn1ccc(-c2ccc3c(c2)ncn3-c2ccc(CC(=O)Nc3cc(C(C)(C)C)on3)cc2)c1
InChIInChI=1S/C27H27N5O2/c1-27(2,3)24-15-25(30-34-24)29-26(33)13-18-5-8-21(9-6-18)32-17-28-22-14-19(7-10-23(22)32)20-11-12-31(4)16-20/h5-12,14-17H,13H2,1-4H3,(H,29,30,33)
InChIKeyREQJIWOWTBYYLI-UHFFFAOYSA-N
XLogP5.50
TPSA77.88 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds5
Heavy Atoms34
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500453.55
LogP ≤ 55.50
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[5-(1-methylpyrrol-3-yl)benzimidazol-1-yl]phenyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[5-(1-methylpyrrol-3-yl)benzimidazol-1-yl]phenyl]acetamide?
The IUPAC name of N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[5-(1-methylpyrrol-3-yl)benzimidazol-1-yl]phenyl]acetamide (CID 134154626) is N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[5-(1-methylpyrrol-3-yl)benzimidazol-1-yl]phenyl]acetamide.
What is the SMILES notation for N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[5-(1-methylpyrrol-3-yl)benzimidazol-1-yl]phenyl]acetamide?
The canonical SMILES for N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[5-(1-methylpyrrol-3-yl)benzimidazol-1-yl]phenyl]acetamide is Cn1ccc(-c2ccc3c(c2)ncn3-c2ccc(CC(=O)Nc3cc(C(C)(C)C)on3)cc2)c1.
What is the InChIKey of N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[5-(1-methylpyrrol-3-yl)benzimidazol-1-yl]phenyl]acetamide?
The InChIKey is REQJIWOWTBYYLI-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H27N5O2/c1-27(2,3)24-15-25(30-34-24)29-26(33)13-18-5-8-21(9-6-18)32-17-28-22-14-19(7-10-23(22)32)20-11-12-31(4)16-20/h5-12,14-17H,13H2,1-4H3,(H,29,30,33).
What are the key properties of N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[5-(1-methylpyrrol-3-yl)benzimidazol-1-yl]phenyl]acetamide?
N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[5-(1-methylpyrrol-3-yl)benzimidazol-1-yl]phenyl]acetamide has a molecular weight of 453.55 g/mol, XLogP of 5.50, 5 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5-tert-butyl-1,2-oxazol-3-yl)-2-[4-[5-(1-methylpyrrol-3-yl)benzimidazol-1-yl]phenyl]acetamide is sourced from PubChem (CID 134154626), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.